(Q33344682)

English

Intermittent weekly high-dose capecitabine in combination with oxaliplatin: a phase I/II study in first-line treatment of patients with advanced colorectal cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Intermittent weekly high-dose capecitabine in combination with oxaliplatin: a phase I/II study in first-line treatment of patients with advanced colorectal cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

author name string

W Scheithauer

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

G V Kornek

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

M Raderer

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

B Schüll

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

K Schmid

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

F Längle

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

H Huber

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1583-1589

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FDKF281

21 January 2018

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FDKF281

21 January 2018

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FDKF281

21 January 2018

Approximate confidence intervals for probabilities of survival and quantiles in life-table analysis.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FDKF281

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FDKF281

21 January 2018

Advanced colorectal cancer: which regimes should we recommend?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FDKF281

21 January 2018

Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FDKF281

21 January 2018

Identifiers

10.1093/ANNONC/DKF281

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33344682&oldid=2050226752"